Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $116.34 | 3 | 56.6% |
| Unspecified | $89.25 | 1 | 43.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $89.25 | 1 | $0 (2019) |
| Novo Nordisk Inc | $78.21 | 1 | $0 (2024) |
| Amgen Inc. | $38.13 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78.21 | 1 | Novo Nordisk Inc ($78.21) |
| 2019 | $89.25 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($89.25) |
| 2018 | $38.13 | 2 | Amgen Inc. ($38.13) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $78.21 | General |
| 03/22/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Ninlaro (Drug) | — | Cash or cash equivalent | $89.25 | Research |
| Study: Study of Dexamethasone Plus IXAZOMIB MLN9708 or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain AL Amyloidosis • Category: Oncology | ||||||
| 08/02/2018 | Amgen Inc. | Neulasta (Biological), Vectibix, XGEVA | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Oncology | ||||||
| 03/05/2018 | Amgen Inc. | Neulasta (Biological), Vectibix, XGEVA | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study of Dexamethasone Plus IXAZOMIB MLN9708 or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain AL Amyloidosis | Takeda Pharmaceuticals U.S.A., Inc. | $89.25 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 36 | 56 | $17,808 | $3,486 |
| 2020 | 2 | 73 | 167 | $53,019 | $9,118 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 36 | 56 | $17,808 | $3,486 | 19.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 47 | 127 | $37,626 | $6,126 | 16.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 26 | 40 | $15,393 | $2,992 | 19.4% |
About Dr. Stacey Goodman, MD
Dr. Stacey Goodman, MD is a Hematology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639278062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Goodman, MD has received a total of $205.59 in payments from pharmaceutical and medical device companies, with $78.21 received in 2024. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($116.34).
As a Medicare-enrolled provider, Goodman has provided services to 109 Medicare beneficiaries, totaling 223 services with total Medicare billing of $12,604. Data is available for 2 years (2020–2021), covering 3 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Location Nashville, TN
- Active Since 09/22/2006
- Last Updated 10/15/2020
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1639278062
Products in Payments
- Ninlaro (Drug) $89.25
- Neulasta (Biological) $38.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Nashville
Dr. Navneet Majhail, Md, MD
Hematology — Payments: $62,360
Dr. Michael Debaun, Md, MD
Hematology — Payments: $39,880
Ben Park, M.d, M.D
Hematology — Payments: $22,841
Dr. Jill Gilbert, Md, MD
Hematology — Payments: $14,607
Wesam Ahmed, Md, MD
Hematology — Payments: $11,770
Dr. Katherine Walsh, M.d, M.D
Hematology — Payments: $7,046